Description
Glucocorticoid receptor agonist-3 Ala-Ala-Mal (Compound Preparation 8) is an anti-human TNFα antibody-glucocorticoid receptor agonist (GC) conjugate. Glucocorticoid receptor agonist-3 Ala-Ala-Mal can be used in the study of autoimmune and inflammatory diseases[1].–20°C (Powder, sealed storage, away from moisture and light)-Applications–Formula-C49H55FN4O12-Citation–References-[1]Grace CHAO, et al. Human tumor necrosis factor alpha antibody glucocorticoid conjugates. Patent WO2023220549A1.-CASNumber-3014393-35-9-MolecularWeight-910.98-Compound Purity-99.72-SMILES-OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@@]5(C(CC4)=CC(C=C5)=O)C)([H])[C@H](C3)O)([H])C[C@@]1([H])O[C@H](C6=C(C(OCC7=CC(NC([C@H](C)NC([C@H](C)NC(CCN8C(C=CC8=O)=O)=O)=O)=O)=CC=C7)=CC=C6C)F)O2)C)=O-Research_Area-Inflammation/Immunology-Solubility-DMSO : 100 mg/mL (ultrasonic)-Target-Drug-Linker Conjugates for ADC;Glucocorticoid Receptor;TNF Receptor-Isoform–Pathway-Antibody-drug Conjugate/ADC Related;Apoptosis;Immunology/Inflammation;Vitamin D Related/Nuclear Receptor-MCE Product type-ADC Related
